Valuation: Mega Lifesciences

Market Cap 3.31TCr 99Cr 86Cr 80Cr 73Cr 138.61Cr 9.51TCr 141.02Cr 951.81Cr 373.9Cr 4.65TCr 370.77Cr 362.63Cr 16TCr P/E 2026 *
14.3x
P/E 2027 * 13.5x
Enterprise Value 2.85TCr 85Cr 74Cr 69Cr 63Cr 119.31Cr 8.19TCr 121.39Cr 819.31Cr 321.85Cr 4TCr 319.16Cr 312.15Cr 14TCr EV / Sales 2026 *
1.92x
EV / Sales 2027 * 1.82x
Free-Float
38.61%
Yield 2026 *
4.6%
Yield 2027 * 4.94%
1 week+2.70%
Current month+3.40%
1 month+11.76%
3 months+10.95%
6 months+9.35%
Current year+13.43%
1 week 36.75
Extreme 36.75
38.5
1 month 34
Extreme 34
38.5
Current year 31.5
Extreme 31.5
40
1 year 26.75
Extreme 26.75
40
3 years 24.3
Extreme 24.3
46.75
5 years 24.3
Extreme 24.3
56.5
10 years 15.9
Extreme 15.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 61 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 61 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Change 5-day change 1-year change 3-year change Capi.($)
0.00%+2.70% - - 99Cr
+1.00%-3.52%+48.67%+162.60% 1,03100Cr
+1.10%-3.51%+51.72%+57.17% 59TCr
+2.96%+1.06%+32.52%+87.31% 43TCr
+0.42%-1.16%+29.43%+23.64% 33TCr
+1.03%-0.84%+29.58%+45.15% 28TCr
+0.49%-5.44%+21.00%+23.80% 26TCr
+1.59%+4.89%-22.56%-37.35% 22TCr
+2.88%+1.70%+23.67%+62.31% 19TCr
+2.90%+0.47%+23.32%+74.85% 16TCr
Average +1.39%-3.79%+26.37%+55.50% 38.94TCr
Weighted average by Cap. +1.36%-4.31%+34.71%+80.40%

Financials

2026 *2027 *
Net sales 1.49TCr 44Cr 39Cr 36Cr 33Cr 62Cr 4.27TCr 63Cr 427.38Cr 167.89Cr 2.09TCr 166.49Cr 162.83Cr 7.2TCr 1.56TCr 47Cr 41Cr 38Cr 35Cr 65Cr 4.48TCr 66Cr 448.51Cr 176.19Cr 2.19TCr 174.72Cr 170.88Cr 7.56TCr
Net income 232Cr 6.91Cr 6.04Cr 5.59Cr 5.13Cr 9.71Cr 666.19Cr 9.87Cr 67Cr 26Cr 325.32Cr 26Cr 25Cr 1.12TCr 245.99Cr 7.33Cr 6.41Cr 5.93Cr 5.44Cr 10Cr 706.37Cr 10Cr 71Cr 28Cr 344.94Cr 28Cr 27Cr 1.19TCr
Net Debt -461.19Cr -14Cr -12Cr -11Cr -10Cr -19Cr -1.32TCr -20Cr -132.49Cr -52Cr -646.7Cr -52Cr -50Cr -2.23TCr -475.63Cr -14Cr -12Cr -11Cr -11Cr -20Cr -1.37TCr -20Cr -136.64Cr -54Cr -666.95Cr -53Cr -52Cr -2.3TCr
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
16/26/16 THB 38.00 0.00% 2,10,900
15/26/15 THB 38.00 +0.66% 8,73,600
14/26/14 THB 37.75 +1.34% 7,37,000
13/26/13 THB 37.25 +0.68% 7,00,000
10/26/10 THB 37.00 -1.33% 7,02,500
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
38.00THB
Average target price
41.14THB
Spread / Average Target
+8.27%

Quarterly revenue - Rate of surprise